\\n\\n
Dr. Pletser’s experience includes 30 years of working with the European Space Agency as a Senior Physicist/Engineer and coordinating their parabolic flight campaigns, and he is the Guinness World Record holder for the most number of aircraft flown (12) in parabolas, personally logging more than 7,300 parabolas.
\\n\\nSeeing the 5,000th book published makes us at the same time proud, happy, humble, and grateful. This is a great opportunity to stop and celebrate what we have done so far, but is also an opportunity to engage even more, grow, and succeed. It wouldn't be possible to get here without the synergy of team members’ hard work and authors and editors who devote time and their expertise into Open Access book publishing with us.
\\n\\nOver these years, we have gone from pioneering the scientific Open Access book publishing field to being the world’s largest Open Access book publisher. Nonetheless, our vision has remained the same: to meet the challenges of making relevant knowledge available to the worldwide community under the Open Access model.
\\n\\nWe are excited about the present, and we look forward to sharing many more successes in the future.
\\n\\nThank you all for being part of the journey. 5,000 times thank you!
\\n\\nNow with 5,000 titles available Open Access, which one will you read next?
\\n\\nRead, share and download for free: https://www.intechopen.com/books
\\n\\n\\n\\n
\\n"}]',published:!0,mainMedia:null},components:[{type:"htmlEditorComponent",content:'
Preparation of Space Experiments edited by international leading expert Dr. Vladimir Pletser, Director of Space Training Operations at Blue Abyss is the 5,000th Open Access book published by IntechOpen and our milestone publication!
\n\n"This book presents some of the current trends in space microgravity research. The eleven chapters introduce various facets of space research in physical sciences, human physiology and technology developed using the microgravity environment not only to improve our fundamental understanding in these domains but also to adapt this new knowledge for application on earth." says the editor. Listen what else Dr. Pletser has to say...
\n\n\n\nDr. Pletser’s experience includes 30 years of working with the European Space Agency as a Senior Physicist/Engineer and coordinating their parabolic flight campaigns, and he is the Guinness World Record holder for the most number of aircraft flown (12) in parabolas, personally logging more than 7,300 parabolas.
\n\nSeeing the 5,000th book published makes us at the same time proud, happy, humble, and grateful. This is a great opportunity to stop and celebrate what we have done so far, but is also an opportunity to engage even more, grow, and succeed. It wouldn't be possible to get here without the synergy of team members’ hard work and authors and editors who devote time and their expertise into Open Access book publishing with us.
\n\nOver these years, we have gone from pioneering the scientific Open Access book publishing field to being the world’s largest Open Access book publisher. Nonetheless, our vision has remained the same: to meet the challenges of making relevant knowledge available to the worldwide community under the Open Access model.
\n\nWe are excited about the present, and we look forward to sharing many more successes in the future.
\n\nThank you all for being part of the journey. 5,000 times thank you!
\n\nNow with 5,000 titles available Open Access, which one will you read next?
\n\nRead, share and download for free: https://www.intechopen.com/books
\n\n\n\n
\n'}],latestNews:[{slug:"stanford-university-identifies-top-2-scientists-over-1-000-are-intechopen-authors-and-editors-20210122",title:"Stanford University Identifies Top 2% Scientists, Over 1,000 are IntechOpen Authors and Editors"},{slug:"intechopen-authors-included-in-the-highly-cited-researchers-list-for-2020-20210121",title:"IntechOpen Authors Included in the Highly Cited Researchers List for 2020"},{slug:"intechopen-maintains-position-as-the-world-s-largest-oa-book-publisher-20201218",title:"IntechOpen Maintains Position as the World’s Largest OA Book Publisher"},{slug:"all-intechopen-books-available-on-perlego-20201215",title:"All IntechOpen Books Available on Perlego"},{slug:"oiv-awards-recognizes-intechopen-s-editors-20201127",title:"OIV Awards Recognizes IntechOpen's Editors"},{slug:"intechopen-joins-crossref-s-initiative-for-open-abstracts-i4oa-to-boost-the-discovery-of-research-20201005",title:"IntechOpen joins Crossref's Initiative for Open Abstracts (I4OA) to Boost the Discovery of Research"},{slug:"intechopen-hits-milestone-5-000-open-access-books-published-20200908",title:"IntechOpen hits milestone: 5,000 Open Access books published!"},{slug:"intechopen-books-hosted-on-the-mathworks-book-program-20200819",title:"IntechOpen Books Hosted on the MathWorks Book Program"}]},book:{item:{type:"book",id:"6062",leadTitle:null,fullTitle:"Advances in Bioremediation and Phytoremediation",title:"Advances in Bioremediation and Phytoremediation",subtitle:null,reviewType:"peer-reviewed",abstract:"The pollution of soil and groundwater by harmful chemical compounds and heavy metals is becoming very serious in many countries. Although remediation is necessary as soon as possible, the performance of conventional bioremediation processes is not sufficient. This book deals with advances in bioremediation and phytoremediation processes by using excellent strains and a combination of processes. In the chapters of this book, the researchers have introduced the overall status of contamination; the characteristics of bioremediation using halobacteria, Candida yeast, and autochthonous bacteria; and phytoremediation using macrophytes. Moreover, other researchers introduced a process using biochar and electric currents, and this combination of processes and phytoremediation enhances the overall process.",isbn:"978-953-51-3958-4",printIsbn:"978-953-51-3957-7",pdfIsbn:"978-953-51-4023-8",doi:"10.5772/67970",price:119,priceEur:129,priceUsd:155,slug:"advances-in-bioremediation-and-phytoremediation",numberOfPages:200,isOpenForSubmission:!1,isInWos:1,hash:"7b537906414bbdbbe7a318c5702ef67e",bookSignature:"Naofumi Shiomi",publishedDate:"April 4th 2018",coverURL:"https://cdn.intechopen.com/books/images_new/6062.jpg",numberOfDownloads:9733,numberOfWosCitations:14,numberOfCrossrefCitations:17,numberOfDimensionsCitations:34,hasAltmetrics:0,numberOfTotalCitations:65,isAvailableForWebshopOrdering:!0,dateEndFirstStepPublish:"February 23rd 2017",dateEndSecondStepPublish:"March 16th 2017",dateEndThirdStepPublish:"September 22nd 2017",dateEndFourthStepPublish:"October 22nd 2017",dateEndFifthStepPublish:"December 22nd 2017",currentStepOfPublishingProcess:5,indexedIn:"1,2,3,4,5,6",editedByType:"Edited by",kuFlag:!1,editors:[{id:"163777",title:"Prof.",name:"Naofumi",middleName:null,surname:"Shiomi",slug:"naofumi-shiomi",fullName:"Naofumi Shiomi",profilePictureURL:"https://mts.intechopen.com/storage/users/163777/images/system/163777.jpeg",biography:"Dr. Naofumi Shiomi studied recombinant yeast and its utilization as a researcher at the Laboratory of Production Technology of Kanena Corporation for 15 years until 1998, and earned his PhD in Engineering from Kyoto University. He now works as a professor at the School of Human Sciences of Kobe College in Japan, where he teaches applied microbiology, biotechnology and life science in his \\Applied Life Science\\ laboratory. He has studied bioremediation for 26 years at Kobe College, and has published more than 40 papers and several book chapters on recombinant microorganisms and bioremediation. His recent research has also focused on the prevention of obesity and aging.",institutionString:"Kobe College",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"7",totalChapterViews:"0",totalEditedBooks:"6",institution:{name:"Kobe College",institutionURL:null,country:{name:"Japan"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,coeditorOne:null,coeditorTwo:null,coeditorThree:null,coeditorFour:null,coeditorFive:null,topics:[{id:"126",title:"Ecology",slug:"environmental-sciences-ecology"}],chapters:[{id:"59373",title:"Introductory Chapter: Serious Pollution of Soil and Groundwater and the Necessity of Bioremediation",doi:"10.5772/intechopen.74403",slug:"introductory-chapter-serious-pollution-of-soil-and-groundwater-and-the-necessity-of-bioremediation",totalDownloads:831,totalCrossrefCites:0,totalDimensionsCites:0,signatures:"Naofumi Shiomi",downloadPdfUrl:"/chapter/pdf-download/59373",previewPdfUrl:"/chapter/pdf-preview/59373",authors:[{id:"163777",title:"Prof.",name:"Naofumi",surname:"Shiomi",slug:"naofumi-shiomi",fullName:"Naofumi Shiomi"}],corrections:null},{id:"58446",title:"The Pollution of Water by Trace Elements Research Trends",doi:"10.5772/intechopen.72776",slug:"the-pollution-of-water-by-trace-elements-research-trends",totalDownloads:1293,totalCrossrefCites:0,totalDimensionsCites:2,signatures:"Khaled Al-Akeel",downloadPdfUrl:"/chapter/pdf-download/58446",previewPdfUrl:"/chapter/pdf-preview/58446",authors:[{id:"212669",title:"Dr.",name:"Khaled",surname:"Alakeel",slug:"khaled-alakeel",fullName:"Khaled Alakeel"}],corrections:null},{id:"58349",title:"Biosorption of Heavy Metals by Candida albicans",doi:"10.5772/intechopen.72454",slug:"biosorption-of-heavy-metals-by-candida-albicans",totalDownloads:881,totalCrossrefCites:3,totalDimensionsCites:6,signatures:"Ismael Acosta Rodríguez, Juan Fernando Cárdenas-González, Víctor\nManuel Martínez Juárez, Adriana Rodríguez Pérez, María de\nGuadalupe Moctezuma Zarate and Nancy Cecilia Pacheco Castillo",downloadPdfUrl:"/chapter/pdf-download/58349",previewPdfUrl:"/chapter/pdf-preview/58349",authors:[{id:"26625",title:"Dr.",name:"Ismael",surname:"Acosta",slug:"ismael-acosta",fullName:"Ismael Acosta"},{id:"214409",title:"Dr.",name:"Juan Fernando",surname:"Cárdenas González",slug:"juan-fernando-cardenas-gonzalez",fullName:"Juan Fernando Cárdenas González"},{id:"214415",title:"Dr.",name:"Adriana Sarai",surname:"Rodríguez Pérez",slug:"adriana-sarai-rodriguez-perez",fullName:"Adriana Sarai Rodríguez Pérez"}],corrections:null},{id:"57078",title:"Recent Trend on Bioremediation of Polluted Salty Soils and Waters Using Haloarchaea",doi:"10.5772/intechopen.70802",slug:"recent-trend-on-bioremediation-of-polluted-salty-soils-and-waters-using-haloarchaea",totalDownloads:713,totalCrossrefCites:3,totalDimensionsCites:5,signatures:"Sonia Aracil-Gisbert, Javier Torregrosa-Crespo and Rosa María\nMartínez-Espinosa",downloadPdfUrl:"/chapter/pdf-download/57078",previewPdfUrl:"/chapter/pdf-preview/57078",authors:[{id:"165627",title:"Dr.",name:"Rosa María",surname:"Martínez-Espinosa",slug:"rosa-maria-martinez-espinosa",fullName:"Rosa María Martínez-Espinosa"},{id:"196514",title:"MSc.",name:"Javier",surname:"Torregrosa-Crespo",slug:"javier-torregrosa-crespo",fullName:"Javier Torregrosa-Crespo"},{id:"207042",title:"Mrs.",name:"Sonia",surname:"Aracil-Gisbert",slug:"sonia-aracil-gisbert",fullName:"Sonia Aracil-Gisbert"}],corrections:null},{id:"56643",title:"Laboratory-Scale Biodegradation of Fuel Oil No. 6 in Contaminated Soils by Autochthonous Bacteria",doi:"10.5772/intechopen.70350",slug:"laboratory-scale-biodegradation-of-fuel-oil-no-6-in-contaminated-soils-by-autochthonous-bacteria",totalDownloads:611,totalCrossrefCites:2,totalDimensionsCites:2,signatures:"Hilda Amelia Piñón-Castillo, Daniel Lardizabal Gutiérrez, Francisco\nJavier Zavala-Díaz de la Serna, Daniel Hernández-Castillo, Laila N.\nMuñoz-Castellanos, Blanca E. Rivera-Chavira and Guadalupe\nVirginia Nevárez-Moorillón",downloadPdfUrl:"/chapter/pdf-download/56643",previewPdfUrl:"/chapter/pdf-preview/56643",authors:[{id:"166633",title:"Dr.",name:"Guadalupe",surname:"Nevárez-Moorillón",slug:"guadalupe-nevarez-moorillon",fullName:"Guadalupe Nevárez-Moorillón"},{id:"175550",title:"Dr.",name:"Blanca E.",surname:"Rivera-Chavira",slug:"blanca-e.-rivera-chavira",fullName:"Blanca E. Rivera-Chavira"},{id:"207108",title:"Dr.",name:"Hilda Amelia",surname:"Piñon-Castillo",slug:"hilda-amelia-pinon-castillo",fullName:"Hilda Amelia Piñon-Castillo"},{id:"207109",title:"MSc.",name:"Daniel",surname:"Lardizabal-Gutiérrez",slug:"daniel-lardizabal-gutierrez",fullName:"Daniel Lardizabal-Gutiérrez"},{id:"207110",title:"Dr.",name:"Daniel",surname:"Hernández-Castillo",slug:"daniel-hernandez-castillo",fullName:"Daniel Hernández-Castillo"},{id:"207111",title:"Dr.",name:"Laila N.",surname:"Muñoz-Castellanos",slug:"laila-n.-munoz-castellanos",fullName:"Laila N. Muñoz-Castellanos"},{id:"211511",title:"Dr.",name:"Francisco Javier",surname:"Zavala-Díaz De La Serna",slug:"francisco-javier-zavala-diaz-de-la-serna",fullName:"Francisco Javier Zavala-Díaz De La Serna"}],corrections:null},{id:"58767",title:"Effectiveness of Sorghum Husk and Chicken Manure in Bioremediation of Crude Oil Contaminated Soil",doi:"10.5772/intechopen.71832",slug:"effectiveness-of-sorghum-husk-and-chicken-manure-in-bioremediation-of-crude-oil-contaminated-soil",totalDownloads:719,totalCrossrefCites:1,totalDimensionsCites:1,signatures:"Feyisayo V. Adams, Maryam F. Awode and Bolade O. Agboola",downloadPdfUrl:"/chapter/pdf-download/58767",previewPdfUrl:"/chapter/pdf-preview/58767",authors:[{id:"187708",title:"Dr.",name:"Bolade",surname:"Agboola",slug:"bolade-agboola",fullName:"Bolade Agboola"},{id:"221377",title:"Dr.",name:"Feyisayo",surname:"Adams",slug:"feyisayo-adams",fullName:"Feyisayo Adams"},{id:"222427",title:"Ms.",name:"Maryam F.",surname:"Awode",slug:"maryam-f.-awode",fullName:"Maryam F. Awode"}],corrections:null},{id:"56666",title:"Heavy Metal Removal with Phytoremediation",doi:"10.5772/intechopen.70330",slug:"heavy-metal-removal-with-phytoremediation",totalDownloads:1692,totalCrossrefCites:1,totalDimensionsCites:3,signatures:"Sevinç Adiloğlu",downloadPdfUrl:"/chapter/pdf-download/56666",previewPdfUrl:"/chapter/pdf-preview/56666",authors:[{id:"205818",title:"Associate Prof.",name:"Sevinç",surname:"Adiloğlu",slug:"sevinc-adiloglu",fullName:"Sevinç Adiloğlu"}],corrections:null},{id:"59817",title:"Potential and Constraints of Macrophyte Manipulation for Shallow Lake Management",doi:"10.5772/intechopen.74046",slug:"potential-and-constraints-of-macrophyte-manipulation-for-shallow-lake-management",totalDownloads:662,totalCrossrefCites:1,totalDimensionsCites:1,signatures:"Zeljka Rudic, Bojana Vujovic, Ljubinko Jovanovic, Dragan Kiković,\nIgor Kljujev, Mile Bozic and Vera Raicevic",downloadPdfUrl:"/chapter/pdf-download/59817",previewPdfUrl:"/chapter/pdf-preview/59817",authors:[{id:"141030",title:"Dr.",name:"Vera",surname:"Raicevic",slug:"vera-raicevic",fullName:"Vera Raicevic"},{id:"143894",title:"MSc.",name:"Mile",surname:"Bozic",slug:"mile-bozic",fullName:"Mile Bozic"},{id:"143896",title:"Dr.",name:"Zeljka",surname:"Rudic",slug:"zeljka-rudic",fullName:"Zeljka Rudic"},{id:"163271",title:"Prof.",name:"Ljubinko",surname:"Jovanovic",slug:"ljubinko-jovanovic",fullName:"Ljubinko Jovanovic"},{id:"239087",title:"Dr.",name:"Bojana",surname:"Vujovic",slug:"bojana-vujovic",fullName:"Bojana Vujovic"},{id:"239091",title:"Dr.",name:"Igor",surname:"Kljujev",slug:"igor-kljujev",fullName:"Igor Kljujev"},{id:"239093",title:"Prof.",name:"Dragan",surname:"Kikovic",slug:"dragan-kikovic",fullName:"Dragan Kikovic"}],corrections:null},{id:"56622",title:"Impact of Biochar on the Bioremediation and Phytoremediation of Heavy Metal(loid)s in Soil",doi:"10.5772/intechopen.70349",slug:"impact-of-biochar-on-the-bioremediation-and-phytoremediation-of-heavy-metal-loid-s-in-soil",totalDownloads:1413,totalCrossrefCites:4,totalDimensionsCites:9,signatures:"Wenjie Sun, Sha Zhang and Chunming Su",downloadPdfUrl:"/chapter/pdf-download/56622",previewPdfUrl:"/chapter/pdf-preview/56622",authors:[{id:"173666",title:"Dr.",name:"Chunming",surname:"Su",slug:"chunming-su",fullName:"Chunming Su"},{id:"205937",title:"Dr.",name:"Wenjie",surname:"Sun",slug:"wenjie-sun",fullName:"Wenjie Sun"},{id:"207000",title:"Mr.",name:"Sha",surname:"Zhang",slug:"sha-zhang",fullName:"Sha Zhang"}],corrections:null},{id:"58996",title:"Enhancement of Bioremediation and Phytoremediation Using Electrokinetics",doi:"10.5772/intechopen.73202",slug:"enhancement-of-bioremediation-and-phytoremediation-using-electrokinetics",totalDownloads:924,totalCrossrefCites:2,totalDimensionsCites:5,signatures:"Ikrema Hassan, Eltayeb Mohamedelhassan, Ernest K. Yanful and Ze-\nChun Yuan",downloadPdfUrl:"/chapter/pdf-download/58996",previewPdfUrl:"/chapter/pdf-preview/58996",authors:[{id:"219949",title:"Dr.",name:"Ikrema",surname:"Hassan",slug:"ikrema-hassan",fullName:"Ikrema Hassan"},{id:"232330",title:"Dr.",name:"Eltayeb",surname:"Mohamedelhassan",slug:"eltayeb-mohamedelhassan",fullName:"Eltayeb Mohamedelhassan"},{id:"232331",title:"Prof.",name:"Ernest",surname:"Yanful",slug:"ernest-yanful",fullName:"Ernest Yanful"},{id:"232332",title:"Dr.",name:"Ze-Chun",surname:"Yuan",slug:"ze-chun-yuan",fullName:"Ze-Chun Yuan"}],corrections:null}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}},relatedBooks:[{type:"book",id:"4602",title:"Advances in Bioremediation of Wastewater and Polluted Soil",subtitle:null,isOpenForSubmission:!1,hash:"8b879725924ff3e5b59fb2f8cc12c562",slug:"advances-in-bioremediation-of-wastewater-and-polluted-soil",bookSignature:"Naofumi Shiomi",coverURL:"https://cdn.intechopen.com/books/images_new/4602.jpg",editedByType:"Edited by",editors:[{id:"163777",title:"Prof.",name:"Naofumi",surname:"Shiomi",slug:"naofumi-shiomi",fullName:"Naofumi Shiomi"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"5701",title:"Superfood and Functional Food",subtitle:"The Development of Superfoods and Their Roles as Medicine",isOpenForSubmission:!1,hash:"0c3c4e9924a0f6c2fe2df43d5dfc50fb",slug:"superfood-and-functional-food-the-development-of-superfoods-and-their-roles-as-medicine",bookSignature:"Naofumi Shiomi and Viduranga Waisundara",coverURL:"https://cdn.intechopen.com/books/images_new/5701.jpg",editedByType:"Edited by",editors:[{id:"163777",title:"Prof.",name:"Naofumi",surname:"Shiomi",slug:"naofumi-shiomi",fullName:"Naofumi Shiomi"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"5258",title:"Molecular Mechanisms of the Aging Process and Rejuvenation",subtitle:null,isOpenForSubmission:!1,hash:"fd825c8a444ab91728c15f350df7b5ea",slug:"molecular-mechanisms-of-the-aging-process-and-rejuvenation",bookSignature:"Naofumi Shiomi",coverURL:"https://cdn.intechopen.com/books/images_new/5258.jpg",editedByType:"Edited by",editors:[{id:"163777",title:"Prof.",name:"Naofumi",surname:"Shiomi",slug:"naofumi-shiomi",fullName:"Naofumi Shiomi"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6538",title:"Current Topics on Superfoods",subtitle:null,isOpenForSubmission:!1,hash:"42525eaf5a539bc1e2318f4eb8dfea5a",slug:"current-topics-on-superfoods",bookSignature:"Naofumi Shiomi",coverURL:"https://cdn.intechopen.com/books/images_new/6538.jpg",editedByType:"Edited by",editors:[{id:"163777",title:"Prof.",name:"Naofumi",surname:"Shiomi",slug:"naofumi-shiomi",fullName:"Naofumi Shiomi"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"7594",title:"Current Topics in Biochemical Engineering",subtitle:null,isOpenForSubmission:!1,hash:"391609f1f0cb3bba32befeb3aa40ccf3",slug:"current-topics-in-biochemical-engineering",bookSignature:"Naofumi Shiomi",coverURL:"https://cdn.intechopen.com/books/images_new/7594.jpg",editedByType:"Edited by",editors:[{id:"163777",title:"Prof.",name:"Naofumi",surname:"Shiomi",slug:"naofumi-shiomi",fullName:"Naofumi Shiomi"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6699",title:"Community and Global Ecology of Deserts",subtitle:null,isOpenForSubmission:!1,hash:"3f9477aa1d898626573100c92fa392e7",slug:"community-and-global-ecology-of-deserts",bookSignature:"Levente Hufnagel",coverURL:"https://cdn.intechopen.com/books/images_new/6699.jpg",editedByType:"Edited by",editors:[{id:"10864",title:"Dr.",name:"Levente",surname:"Hufnagel",slug:"levente-hufnagel",fullName:"Levente Hufnagel"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1591",title:"Infrared Spectroscopy",subtitle:"Materials Science, Engineering and Technology",isOpenForSubmission:!1,hash:"99b4b7b71a8caeb693ed762b40b017f4",slug:"infrared-spectroscopy-materials-science-engineering-and-technology",bookSignature:"Theophile Theophanides",coverURL:"https://cdn.intechopen.com/books/images_new/1591.jpg",editedByType:"Edited by",editors:[{id:"37194",title:"Dr.",name:"Theophanides",surname:"Theophile",slug:"theophanides-theophile",fullName:"Theophanides Theophile"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3092",title:"Anopheles mosquitoes",subtitle:"New insights into malaria vectors",isOpenForSubmission:!1,hash:"c9e622485316d5e296288bf24d2b0d64",slug:"anopheles-mosquitoes-new-insights-into-malaria-vectors",bookSignature:"Sylvie Manguin",coverURL:"https://cdn.intechopen.com/books/images_new/3092.jpg",editedByType:"Edited by",editors:[{id:"50017",title:"Prof.",name:"Sylvie",surname:"Manguin",slug:"sylvie-manguin",fullName:"Sylvie Manguin"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3161",title:"Frontiers in Guided Wave Optics and Optoelectronics",subtitle:null,isOpenForSubmission:!1,hash:"deb44e9c99f82bbce1083abea743146c",slug:"frontiers-in-guided-wave-optics-and-optoelectronics",bookSignature:"Bishnu Pal",coverURL:"https://cdn.intechopen.com/books/images_new/3161.jpg",editedByType:"Edited by",editors:[{id:"4782",title:"Prof.",name:"Bishnu",surname:"Pal",slug:"bishnu-pal",fullName:"Bishnu Pal"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"72",title:"Ionic Liquids",subtitle:"Theory, Properties, New Approaches",isOpenForSubmission:!1,hash:"d94ffa3cfa10505e3b1d676d46fcd3f5",slug:"ionic-liquids-theory-properties-new-approaches",bookSignature:"Alexander Kokorin",coverURL:"https://cdn.intechopen.com/books/images_new/72.jpg",editedByType:"Edited by",editors:[{id:"19816",title:"Prof.",name:"Alexander",surname:"Kokorin",slug:"alexander-kokorin",fullName:"Alexander Kokorin"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],ofsBooks:[]},correction:{item:{id:"65669",slug:"corrigendum-to-aedes-what-do-we-know-about-them-and-what-can-they-transmit",title:"Corrigendum to: Aedes: What Do We Know about Them and What Can They Transmit?",doi:null,correctionPDFUrl:"https://cdn.intechopen.com/pdfs/65669.pdf",downloadPdfUrl:"/chapter/pdf-download/65669",previewPdfUrl:"/chapter/pdf-preview/65669",totalDownloads:null,totalCrossrefCites:null,bibtexUrl:"/chapter/bibtex/65669",risUrl:"/chapter/ris/65669",chapter:{id:"63773",slug:"aedes-what-do-we-know-about-them-and-what-can-they-transmit-",signatures:"Biswadeep Das, Sayam Ghosal and Swabhiman Mohanty",dateSubmitted:"May 16th 2018",dateReviewed:"September 7th 2018",datePrePublished:"November 5th 2018",datePublished:null,book:{id:"8122",title:"Vectors and Vector-Borne Zoonotic Diseases",subtitle:null,fullTitle:"Vectors and Vector-Borne Zoonotic Diseases",slug:"vectors-and-vector-borne-zoonotic-diseases",publishedDate:"February 20th 2019",bookSignature:"Sara Savić",coverURL:"https://cdn.intechopen.com/books/images_new/8122.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",editors:[{id:"92185",title:"Dr.",name:"Sara",middleName:null,surname:"Savic",slug:"sara-savic",fullName:"Sara Savic"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}},authors:null}},chapter:{id:"63773",slug:"aedes-what-do-we-know-about-them-and-what-can-they-transmit-",signatures:"Biswadeep Das, Sayam Ghosal and Swabhiman Mohanty",dateSubmitted:"May 16th 2018",dateReviewed:"September 7th 2018",datePrePublished:"November 5th 2018",datePublished:null,book:{id:"8122",title:"Vectors and Vector-Borne Zoonotic Diseases",subtitle:null,fullTitle:"Vectors and Vector-Borne Zoonotic Diseases",slug:"vectors-and-vector-borne-zoonotic-diseases",publishedDate:"February 20th 2019",bookSignature:"Sara Savić",coverURL:"https://cdn.intechopen.com/books/images_new/8122.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",editors:[{id:"92185",title:"Dr.",name:"Sara",middleName:null,surname:"Savic",slug:"sara-savic",fullName:"Sara Savic"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}},authors:null},book:{id:"8122",title:"Vectors and Vector-Borne Zoonotic Diseases",subtitle:null,fullTitle:"Vectors and Vector-Borne Zoonotic Diseases",slug:"vectors-and-vector-borne-zoonotic-diseases",publishedDate:"February 20th 2019",bookSignature:"Sara Savić",coverURL:"https://cdn.intechopen.com/books/images_new/8122.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",editors:[{id:"92185",title:"Dr.",name:"Sara",middleName:null,surname:"Savic",slug:"sara-savic",fullName:"Sara Savic"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}}},ofsBook:{item:{type:"book",id:"9504",leadTitle:null,title:"Evidence-Based Approaches to Effectively Respond to Public Health Emergencies",subtitle:null,reviewType:"peer-reviewed",abstract:"
\r\n\tResponding to global public health emergencies require well-tested and effective approaches. During the current pandemic, healthcare systems worldwide were ill-prepared to respond to the rapid and far reaching impact of COVID-19. This should prompt researchers to re-examine policies, practices, methods and approaches that governments, health care and civic organizations may use to address health emergencies. With over 100 years of research on the implementation of innovative practices, system and organizational scientists are poised to help states, health care systems and other systems to develop, establish and employ evidence-based practices (EBPs) to effectively respond to public health emergencies.
\r\n\r\n\tThe primary aim of this book is to present theoretical and empirical knowledge on evidence-based policies, organizational practices, group and individual practices and approaches that may allow States and healthcare systems to effectively confront current (e.g., the COVID-19 pandemic), ongoing (e.g. HIV, opioid overdose) and upcoming epidemics affecting population health. The overall goal of this book is to advance knowledge on the development and dissemination of EBPs that contribute to a responsive, coordinated, reliable and effective public health system.
",isbn:"978-1-83969-144-7",printIsbn:"978-1-83969-143-0",pdfIsbn:"978-1-83969-145-4",doi:null,price:0,priceEur:0,priceUsd:0,slug:null,numberOfPages:0,isOpenForSubmission:!1,hash:"355f26e9a65d22c4de7311a424d1e3eb",bookSignature:"Dr. Erick Guerrero",publishedDate:null,coverURL:"https://cdn.intechopen.com/books/images_new/9504.jpg",keywords:"Implementation, Dynamic Systems, Public Health, Emergencies, Coordination, Collaboration, Networks, Teams, Organizational Learning, Implementation, Public Health Crises, Pay for Performance",numberOfDownloads:null,numberOfWosCitations:0,numberOfCrossrefCitations:null,numberOfDimensionsCitations:null,numberOfTotalCitations:null,isAvailableForWebshopOrdering:!0,dateEndFirstStepPublish:"October 19th 2020",dateEndSecondStepPublish:"November 27th 2020",dateEndThirdStepPublish:"January 26th 2021",dateEndFourthStepPublish:"April 16th 2021",dateEndFifthStepPublish:"June 15th 2021",remainingDaysToSecondStep:"3 months",secondStepPassed:!0,currentStepOfPublishingProcess:4,editedByType:null,kuFlag:!1,biosketch:"Dr. Erick Guerrero is an internationally recognized researcher in healthcare access and redesign and Co-Principal Investigator in several public health research projects in the United States, Latin American, and Europe. He is also leading culturally responsive consortiums to respond to other public health crises including institutional racism and COVID-19.",coeditorOneBiosketch:null,coeditorTwoBiosketch:null,coeditorThreeBiosketch:null,coeditorFourBiosketch:null,coeditorFiveBiosketch:null,editors:[{id:"294761",title:"Dr.",name:"Erick",middleName:null,surname:"Guerrero",slug:"erick-guerrero",fullName:"Erick Guerrero",profilePictureURL:"https://mts.intechopen.com/storage/users/294761/images/system/294761.jpg",biography:"Erick Guerrero completed his doctoral degree at the University of Chicago in 2009. In 2016, Dr. Guerrero received tenure as Associate Professor at the University of Southern California. Since 2018, he has been serving as the Founder and Director at the I-LEAD Institute, a research and consulting firm in Silicon Beach. Dr Guerrero has a background in clinical psychology and organizational behavior. As a clinician, he has provided counseling to individuals and families for the past 23 years. As an organizational researcher, Dr Guerrero has published more than 60 peer-reviewed manuscripts and 2 books on implementation of evidence-based practices in health and human service organizations. Dr Guerrero currently co-leads three large studies on disparities and implementation research to respond to the opioid epidemic funded by the U.S. National Institute of Health. He is also leading culturally responsive consortiums to respond to other public health crises including institutional racism and COVID-19.",institutionString:"I-Lead Institute",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"3",totalChapterViews:"0",totalEditedBooks:"1",institution:null}],coeditorOne:null,coeditorTwo:null,coeditorThree:null,coeditorFour:null,coeditorFive:null,topics:[{id:"16",title:"Medicine",slug:"medicine"}],chapters:null,productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"},personalPublishingAssistant:{id:"259492",firstName:"Sara",lastName:"Gojević-Zrnić",middleName:null,title:"Mrs.",imageUrl:"https://mts.intechopen.com/storage/users/259492/images/7469_n.png",email:"sara.p@intechopen.com",biography:"As an Author Service Manager my responsibilities include monitoring and facilitating all publishing activities for authors and editors. From chapter submission and review, to approval and revision, copyediting and design, until final publication, I work closely with authors and editors to ensure a simple and easy publishing process. I maintain constant and effective communication with authors, editors and reviewers, which allows for a level of personal support that enables contributors to fully commit and concentrate on the chapters they are writing, editing, or reviewing. I assist authors in the preparation of their full chapter submissions and track important deadlines and ensure they are met. I help to coordinate internal processes such as linguistic review, and monitor the technical aspects of the process. As an ASM I am also involved in the acquisition of editors. Whether that be identifying an exceptional author and proposing an editorship collaboration, or contacting researchers who would like the opportunity to work with IntechOpen, I establish and help manage author and editor acquisition and contact."}},relatedBooks:[{type:"book",id:"8335",title:"Effective Prevention and Treatment of Substance Use Disorders for Racial and Ethnic Minorities",subtitle:null,isOpenForSubmission:!1,hash:"ca6c7d5d975b1fa9ce320b1162b0dad6",slug:"effective-prevention-and-treatment-of-substance-use-disorders-for-racial-and-ethnic-minorities",bookSignature:"Erick Guerrero and Tenie Khachikian",coverURL:"https://cdn.intechopen.com/books/images_new/8335.jpg",editedByType:"Edited by",editors:[{id:"294761",title:"Dr.",name:"Erick",surname:"Guerrero",slug:"erick-guerrero",fullName:"Erick Guerrero"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6550",title:"Cohort Studies in Health Sciences",subtitle:null,isOpenForSubmission:!1,hash:"01df5aba4fff1a84b37a2fdafa809660",slug:"cohort-studies-in-health-sciences",bookSignature:"R. Mauricio Barría",coverURL:"https://cdn.intechopen.com/books/images_new/6550.jpg",editedByType:"Edited by",editors:[{id:"88861",title:"Dr.",name:"R. Mauricio",surname:"Barría",slug:"r.-mauricio-barria",fullName:"R. Mauricio Barría"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1591",title:"Infrared Spectroscopy",subtitle:"Materials Science, Engineering and Technology",isOpenForSubmission:!1,hash:"99b4b7b71a8caeb693ed762b40b017f4",slug:"infrared-spectroscopy-materials-science-engineering-and-technology",bookSignature:"Theophile Theophanides",coverURL:"https://cdn.intechopen.com/books/images_new/1591.jpg",editedByType:"Edited by",editors:[{id:"37194",title:"Dr.",name:"Theophanides",surname:"Theophile",slug:"theophanides-theophile",fullName:"Theophanides Theophile"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3092",title:"Anopheles mosquitoes",subtitle:"New insights into malaria vectors",isOpenForSubmission:!1,hash:"c9e622485316d5e296288bf24d2b0d64",slug:"anopheles-mosquitoes-new-insights-into-malaria-vectors",bookSignature:"Sylvie Manguin",coverURL:"https://cdn.intechopen.com/books/images_new/3092.jpg",editedByType:"Edited by",editors:[{id:"50017",title:"Prof.",name:"Sylvie",surname:"Manguin",slug:"sylvie-manguin",fullName:"Sylvie Manguin"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3161",title:"Frontiers in Guided Wave Optics and Optoelectronics",subtitle:null,isOpenForSubmission:!1,hash:"deb44e9c99f82bbce1083abea743146c",slug:"frontiers-in-guided-wave-optics-and-optoelectronics",bookSignature:"Bishnu Pal",coverURL:"https://cdn.intechopen.com/books/images_new/3161.jpg",editedByType:"Edited by",editors:[{id:"4782",title:"Prof.",name:"Bishnu",surname:"Pal",slug:"bishnu-pal",fullName:"Bishnu Pal"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"72",title:"Ionic Liquids",subtitle:"Theory, Properties, New Approaches",isOpenForSubmission:!1,hash:"d94ffa3cfa10505e3b1d676d46fcd3f5",slug:"ionic-liquids-theory-properties-new-approaches",bookSignature:"Alexander Kokorin",coverURL:"https://cdn.intechopen.com/books/images_new/72.jpg",editedByType:"Edited by",editors:[{id:"19816",title:"Prof.",name:"Alexander",surname:"Kokorin",slug:"alexander-kokorin",fullName:"Alexander Kokorin"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1373",title:"Ionic Liquids",subtitle:"Applications and Perspectives",isOpenForSubmission:!1,hash:"5e9ae5ae9167cde4b344e499a792c41c",slug:"ionic-liquids-applications-and-perspectives",bookSignature:"Alexander Kokorin",coverURL:"https://cdn.intechopen.com/books/images_new/1373.jpg",editedByType:"Edited by",editors:[{id:"19816",title:"Prof.",name:"Alexander",surname:"Kokorin",slug:"alexander-kokorin",fullName:"Alexander Kokorin"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"57",title:"Physics and Applications of Graphene",subtitle:"Experiments",isOpenForSubmission:!1,hash:"0e6622a71cf4f02f45bfdd5691e1189a",slug:"physics-and-applications-of-graphene-experiments",bookSignature:"Sergey Mikhailov",coverURL:"https://cdn.intechopen.com/books/images_new/57.jpg",editedByType:"Edited by",editors:[{id:"16042",title:"Dr.",name:"Sergey",surname:"Mikhailov",slug:"sergey-mikhailov",fullName:"Sergey Mikhailov"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"371",title:"Abiotic Stress in Plants",subtitle:"Mechanisms and Adaptations",isOpenForSubmission:!1,hash:"588466f487e307619849d72389178a74",slug:"abiotic-stress-in-plants-mechanisms-and-adaptations",bookSignature:"Arun Shanker and B. Venkateswarlu",coverURL:"https://cdn.intechopen.com/books/images_new/371.jpg",editedByType:"Edited by",editors:[{id:"58592",title:"Dr.",name:"Arun",surname:"Shanker",slug:"arun-shanker",fullName:"Arun Shanker"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"878",title:"Phytochemicals",subtitle:"A Global Perspective of Their Role in Nutrition and Health",isOpenForSubmission:!1,hash:"ec77671f63975ef2d16192897deb6835",slug:"phytochemicals-a-global-perspective-of-their-role-in-nutrition-and-health",bookSignature:"Venketeshwer Rao",coverURL:"https://cdn.intechopen.com/books/images_new/878.jpg",editedByType:"Edited by",editors:[{id:"82663",title:"Dr.",name:"Venketeshwer",surname:"Rao",slug:"venketeshwer-rao",fullName:"Venketeshwer Rao"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}]},chapter:{item:{type:"chapter",id:"20189",title:"Aminoacyl-tRNA Synthetases in Idiopathic Inflammatory Myopathies: An Update on Immunopathogenic Significance, Clinical and Therapeutic Implications",doi:"10.5772/19615",slug:"aminoacyl-trna-synthetases-in-idiopathic-inflammatory-myopathies-an-update-on-immunopathogenic-signi",body:null,keywords:null,chapterPDFUrl:"https://cdn.intechopen.com/pdfs/20189.pdf",chapterXML:null,downloadPdfUrl:"/chapter/pdf-download/20189",previewPdfUrl:"/chapter/pdf-preview/20189",totalDownloads:2101,totalViews:92,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:0,dateSubmitted:"November 4th 2010",dateReviewed:"April 26th 2011",datePrePublished:null,datePublished:"September 15th 2011",dateFinished:null,readingETA:"0",abstract:null,reviewType:"peer-reviewed",bibtexUrl:"/chapter/bibtex/20189",risUrl:"/chapter/ris/20189",book:{slug:"idiopathic-inflammatory-myopathies-recent-developments"},signatures:"Codrina Mihaela Ancuta, Eugen Ancuta and Rodica Marieta Chirieac",authors:[{id:"35586",title:"Prof.",name:"Codrina",middleName:null,surname:"Ancuta",fullName:"Codrina Ancuta",slug:"codrina-ancuta",email:"alexia02ro@yahoo.com",position:null,institution:null},{id:"53221",title:"MSc.",name:"Eugen",middleName:null,surname:"Ancuta",fullName:"Eugen Ancuta",slug:"eugen-ancuta",email:"eugen01ro@yahoo.com",position:null,institution:null},{id:"53222",title:"Prof.",name:"Rodica",middleName:null,surname:"Chirieac",fullName:"Rodica Chirieac",slug:"rodica-chirieac",email:"chiriac01ro@yahoo.com",position:null,institution:null}],sections:null,chapterReferences:null,footnotes:null,contributors:null,corrections:null},book:{id:"289",title:"Idiopathic Inflammatory Myopathies",subtitle:"Recent Developments",fullTitle:"Idiopathic Inflammatory Myopathies - Recent Developments",slug:"idiopathic-inflammatory-myopathies-recent-developments",publishedDate:"September 15th 2011",bookSignature:"Jan Tore Gran",coverURL:"https://cdn.intechopen.com/books/images_new/289.jpg",licenceType:"CC BY-NC-SA 3.0",editedByType:"Edited by",editors:[{id:"42398",title:"Prof.",name:"Jan Tore",middleName:null,surname:"Gran",slug:"jan-tore-gran",fullName:"Jan Tore Gran"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"},chapters:[{id:"20185",title:"Idiopathic Inflammatory Myopathies: A Review of Immunopathological Features and Current Models of Pathogenesis",slug:"idiopathic-inflammatory-myopathies-a-review-of-immunopathological-features-and-current-models-of-pat",totalDownloads:2582,totalCrossrefCites:1,signatures:"Cristina Cappelletti, Lucia Morandi, Marina Mora, Franco Salerno, Paolo Confalonieri, Renato Mantegazza and Pia Bernasconi",authors:[{id:"46455",title:"Dr.",name:"Pia",middleName:null,surname:"Bernasconi",fullName:"Pia Bernasconi",slug:"pia-bernasconi"},{id:"52185",title:"Dr.",name:"Cristina",middleName:null,surname:"Cappelletti",fullName:"Cristina Cappelletti",slug:"cristina-cappelletti"},{id:"52186",title:"Dr.",name:"Lucia",middleName:null,surname:"Morandi",fullName:"Lucia Morandi",slug:"lucia-morandi"},{id:"52187",title:"Dr.",name:"Marina",middleName:null,surname:"Mora",fullName:"Marina Mora",slug:"marina-mora"},{id:"52188",title:"BSc.",name:"Franco",middleName:null,surname:"Salerno",fullName:"Franco Salerno",slug:"franco-salerno"},{id:"52189",title:"Dr.",name:"Paolo",middleName:null,surname:"Confalonieri",fullName:"Paolo Confalonieri",slug:"paolo-confalonieri"},{id:"52190",title:"Dr.",name:"Renato",middleName:null,surname:"Mantegazza",fullName:"Renato Mantegazza",slug:"renato-mantegazza"}]},{id:"20186",title:"Serological Aspects of Myositis",slug:"serological-aspects-of-myositis",totalDownloads:2109,totalCrossrefCites:0,signatures:"Johannes Schulte-Pelkum",authors:[{id:"48029",title:"Dr.",name:"Johannes",middleName:null,surname:"Schulte-Pelkum",fullName:"Johannes Schulte-Pelkum",slug:"johannes-schulte-pelkum"}]},{id:"20187",title:"Arthrogenic Alphaviruses and Inflammatory Myopathies",slug:"arthrogenic-alphaviruses-and-inflammatory-myopathies",totalDownloads:1957,totalCrossrefCites:1,signatures:"Lara Herrero and Suresh Mahalingam",authors:[{id:"55575",title:"Prof.",name:"Suresh",middleName:null,surname:"Mahalingam",fullName:"Suresh Mahalingam",slug:"suresh-mahalingam"},{id:"80655",title:"Dr.",name:"Lara",middleName:null,surname:"Herrero",fullName:"Lara Herrero",slug:"lara-herrero"}]},{id:"20188",title:"The Antisynthetase Syndrome",slug:"the-antisynthetase-syndrome",totalDownloads:2184,totalCrossrefCites:0,signatures:"Jan Tore Gran and Øyvind Molberg",authors:[{id:"42398",title:"Prof.",name:"Jan Tore",middleName:null,surname:"Gran",fullName:"Jan Tore Gran",slug:"jan-tore-gran"},{id:"58254",title:"Mr.",name:"Øyvind",middleName:null,surname:"Molberg",fullName:"Øyvind Molberg",slug:"oyvind-molberg"}]},{id:"20189",title:"Aminoacyl-tRNA Synthetases in Idiopathic Inflammatory Myopathies: An Update on Immunopathogenic Significance, Clinical and Therapeutic Implications",slug:"aminoacyl-trna-synthetases-in-idiopathic-inflammatory-myopathies-an-update-on-immunopathogenic-signi",totalDownloads:2101,totalCrossrefCites:0,signatures:"Codrina Mihaela Ancuta, Eugen Ancuta and Rodica Marieta Chirieac",authors:[{id:"35586",title:"Prof.",name:"Codrina",middleName:null,surname:"Ancuta",fullName:"Codrina Ancuta",slug:"codrina-ancuta"},{id:"53221",title:"MSc.",name:"Eugen",middleName:null,surname:"Ancuta",fullName:"Eugen Ancuta",slug:"eugen-ancuta"},{id:"53222",title:"Prof.",name:"Rodica",middleName:null,surname:"Chirieac",fullName:"Rodica Chirieac",slug:"rodica-chirieac"}]},{id:"20190",title:"Interstitial Lung Disease Associated with Clinically Amyopathic Dermatomyositis",slug:"interstitial-lung-disease-associated-with-clinically-amyopathic-dermatomyositis",totalDownloads:3129,totalCrossrefCites:0,signatures:"Toshinori Takada, Eiichi Suzuki and Ichiei Narita",authors:[{id:"35351",title:"Dr.",name:"Toshinori",middleName:null,surname:"Takada",fullName:"Toshinori Takada",slug:"toshinori-takada"},{id:"48653",title:"Prof.",name:"Eiichi",middleName:null,surname:"Suzuki",fullName:"Eiichi Suzuki",slug:"eiichi-suzuki"},{id:"48654",title:"Prof.",name:"Ichiei",middleName:null,surname:"Narita",fullName:"Ichiei Narita",slug:"ichiei-narita"}]},{id:"20191",title:"Myositis and Cancer",slug:"myositis-and-cancer",totalDownloads:2475,totalCrossrefCites:0,signatures:"Sergio Prieto-González, Vladimir Lazo, Ernesto Trallero-Araguás, Albert Selva-O’Callaghan and Josep M Grau",authors:[{id:"32866",title:"Dr.",name:"Sergio",middleName:null,surname:"Prieto-González",fullName:"Sergio Prieto-González",slug:"sergio-prieto-gonzalez"},{id:"37345",title:"Prof.",name:"Josep M.",middleName:null,surname:"Grau",fullName:"Josep M. Grau",slug:"josep-m.-grau"},{id:"53314",title:"Prof.",name:"Albert",middleName:null,surname:"Selva-O'Callaghan",fullName:"Albert Selva-O'Callaghan",slug:"albert-selva-o'callaghan"},{id:"53315",title:"Dr.",name:"Vladimir",middleName:"Yakimtseva",surname:"Lazo",fullName:"Vladimir Lazo",slug:"vladimir-lazo"},{id:"53316",title:"Dr.",name:"Ernesto",middleName:null,surname:"Trallero-Araguas",fullName:"Ernesto Trallero-Araguas",slug:"ernesto-trallero-araguas"}]},{id:"20192",title:"Orbital Myositis",slug:"orbital-myositis",totalDownloads:5170,totalCrossrefCites:2,signatures:"Toshinobu Kubota",authors:[{id:"35321",title:"Dr.",name:"Toshinobu",middleName:null,surname:"Kubota",fullName:"Toshinobu Kubota",slug:"toshinobu-kubota"}]},{id:"20193",title:"Myouclear Breakdown in Sporadic Inclusion Body Myositis",slug:"myouclear-breakdown-in-sporadic-inclusion-body-myositis",totalDownloads:1662,totalCrossrefCites:0,signatures:"Satoshi Nakano and Hirofumi Kusaka",authors:[{id:"42254",title:"Dr.",name:"Satoshi",middleName:null,surname:"Nakano",fullName:"Satoshi Nakano",slug:"satoshi-nakano"},{id:"56682",title:"Prof.",name:"Hirofumi",middleName:null,surname:"Kusaka",fullName:"Hirofumi Kusaka",slug:"hirofumi-kusaka"}]},{id:"20194",title:"Immunoglobulin Treatment in Polymyositis and Dermatomyositis",slug:"immunoglobulin-treatment-in-polymyositis-and-dermatomyositis",totalDownloads:4160,totalCrossrefCites:0,signatures:"Maria Giovanna Danieli, Lucia Pettinari, Romina Moretti, Francesco Logullo and Armando Gabrielli",authors:[{id:"49737",title:"Prof.",name:"Maria Giovanna",middleName:null,surname:"Danieli",fullName:"Maria Giovanna Danieli",slug:"maria-giovanna-danieli"},{id:"90527",title:"Dr.",name:"Lucia",middleName:null,surname:"Pettinari",fullName:"Lucia Pettinari",slug:"lucia-pettinari"},{id:"90528",title:"Dr.",name:"Romina",middleName:null,surname:"Moretti",fullName:"Romina Moretti",slug:"romina-moretti"},{id:"90531",title:"Dr.",name:"Francesco",middleName:null,surname:"Logullo",fullName:"Francesco Logullo",slug:"francesco-logullo"},{id:"90532",title:"Prof.",name:"Armando",middleName:null,surname:"Gabrielli",fullName:"Armando Gabrielli",slug:"armando-gabrielli"}]},{id:"20195",title:"Pregnancy in Myositis: Challenges and Pitfalls",slug:"pregnancy-in-myositis-challenges-and-pitfalls",totalDownloads:3032,totalCrossrefCites:0,signatures:"Codrina Mihaela Ancuta, Eugen Ancuta and Rodica Marieta Chirieac",authors:[{id:"35586",title:"Prof.",name:"Codrina",middleName:null,surname:"Ancuta",fullName:"Codrina Ancuta",slug:"codrina-ancuta"},{id:"53221",title:"MSc.",name:"Eugen",middleName:null,surname:"Ancuta",fullName:"Eugen Ancuta",slug:"eugen-ancuta"},{id:"53222",title:"Prof.",name:"Rodica",middleName:null,surname:"Chirieac",fullName:"Rodica Chirieac",slug:"rodica-chirieac"}]}]},relatedBooks:[{type:"book",id:"1388",title:"Autoimmune Disorders",subtitle:"Current Concepts and Advances from Bedside to Mechanistic Insights",isOpenForSubmission:!1,hash:"f3365e915e5d7c7299da6c076aa5cf24",slug:"autoimmune-disorders-current-concepts-and-advances-from-bedside-to-mechanistic-insights",bookSignature:"Fang-Ping Huang",coverURL:"https://cdn.intechopen.com/books/images_new/1388.jpg",editedByType:"Edited by",editors:[{id:"42618",title:"Dr.",name:"Fang-Ping",surname:"Huang",slug:"fang-ping-huang",fullName:"Fang-Ping Huang"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"},chapters:[{id:"20659",title:"Autoimmune Disorders Associated to Type 1 Diabetes Mellitus in Children and Adolescents",slug:"autoimmune-disorders-associated-to-type-1-diabetes-mellitus-in-children-and-adolescents",signatures:"Giuseppe d’Annunzio and Chiara Russo, Ramona Tallone and Renata Lorini",authors:[{id:"39758",title:"Dr.",name:"Giuseppe",middleName:null,surname:"D'Annunzio",fullName:"Giuseppe D'Annunzio",slug:"giuseppe-d'annunzio"},{id:"52571",title:"Dr.",name:"Chiara",middleName:null,surname:"Russo",fullName:"Chiara Russo",slug:"chiara-russo"},{id:"52572",title:"Prof.",name:"Renata",middleName:null,surname:"Lorini",fullName:"Renata Lorini",slug:"renata-lorini"},{id:"53744",title:"Dr.",name:"Ramona",middleName:null,surname:"Tallone",fullName:"Ramona Tallone",slug:"ramona-tallone"}]},{id:"20660",title:"Hashimoto's Thyroiditis in Children and Adolescents",slug:"hashimoto-s-thyroiditis-in-children-and-adolescents",signatures:"Erkan Sarı, Abdulbaki Karaoglu and Ediz Yeşilkaya",authors:[{id:"59265",title:"Dr.",name:"Ediz",middleName:null,surname:"Yesilkaya",fullName:"Ediz Yesilkaya",slug:"ediz-yesilkaya"},{id:"59267",title:"Dr.",name:"Erkan",middleName:null,surname:"Sari",fullName:"Erkan Sari",slug:"erkan-sari"},{id:"91048",title:"Dr.",name:"Abdulbaki",middleName:null,surname:"Karaoglu",fullName:"Abdulbaki Karaoglu",slug:"abdulbaki-karaoglu"}]},{id:"20661",title:"Primary Sjögren’s Syndrome: Current Pathophysiological, Diagnostic and Therapeutic Advances",slug:"primary-sjo-gren-s-syndrome-current-pathophysiological-diagnostic-and-therapeutic-advances",signatures:"Christine Delporte, Jason Perret and Muhammad S. Soyfoo",authors:[{id:"40743",title:"Prof.",name:"Christine",middleName:null,surname:"Delporte",fullName:"Christine Delporte",slug:"christine-delporte"},{id:"51555",title:"Prof.",name:"Jason",middleName:null,surname:"Perret",fullName:"Jason Perret",slug:"jason-perret"},{id:"51556",title:"Dr",name:"Muhammad",middleName:"Shahnawaz",surname:"Soyfoo",fullName:"Muhammad Soyfoo",slug:"muhammad-soyfoo"}]},{id:"20662",title:"Changing Spectrum of Chronic Immune Thrombocytopenic Purpura: New Face for an Old Disease",slug:"changing-spectrum-of-chronic-immune-thrombocytopenic-purpura-new-face-for-an-old-disease",signatures:"Indu Sabnani and Patricia Tsang",authors:[{id:"53121",title:"Dr.",name:"Indu",middleName:null,surname:"Sabnani",fullName:"Indu Sabnani",slug:"indu-sabnani"},{id:"53153",title:"Dr.",name:"Patricia",middleName:null,surname:"Tsang",fullName:"Patricia Tsang",slug:"patricia-tsang"}]},{id:"23462",title:"Autoimmune-Associated Hemophagocytic Syndrome/Macrophage Activation Syndrome",slug:"autoimmune-associated-hemophagocytic-syndrome-macrophage-activation-syndrome",signatures:"Maciej Machaczka, Wojciech Sydor, Małgorzata Rucińska, Marta Szostek and Jacek Musiał",authors:[{id:"37510",title:"Dr.",name:"Maciej",middleName:"J.",surname:"Machaczka",fullName:"Maciej Machaczka",slug:"maciej-machaczka"},{id:"53497",title:"Dr.",name:"Malgorzata",middleName:"Maria",surname:"Rucinska",fullName:"Malgorzata Rucinska",slug:"malgorzata-rucinska"},{id:"93873",title:"Dr.",name:"Wojciech",middleName:"J.",surname:"Sydor",fullName:"Wojciech Sydor",slug:"wojciech-sydor"},{id:"93874",title:"Dr.",name:"Marta",middleName:null,surname:"Szostek",fullName:"Marta Szostek",slug:"marta-szostek"},{id:"93875",title:"Prof.",name:"Jacek",middleName:null,surname:"Musial",fullName:"Jacek Musial",slug:"jacek-musial"}]},{id:"20664",title:"Ocular Myasthenia Analysis of Diagnostic and Treatment Options",slug:"ocular-myasthenia-analysis-of-diagnostic-and-treatment-options",signatures:"Austin Hake and Henry J. Kaminski",authors:[{id:"40795",title:"Dr.",name:"Henry",middleName:null,surname:"Kaminski",fullName:"Henry Kaminski",slug:"henry-kaminski"},{id:"136016",title:"Prof.",name:"Austin",middleName:null,surname:"Hake",fullName:"Austin Hake",slug:"austin-hake"}]},{id:"20665",title:"Sweet Syndrome",slug:"sweet-syndrome",signatures:"Manuel Ginarte and Jaime Toribio",authors:[{id:"35090",title:"Dr.",name:"Manuel",middleName:null,surname:"Ginarte",fullName:"Manuel Ginarte",slug:"manuel-ginarte"},{id:"136018",title:"Dr.",name:"Jaime",middleName:null,surname:"Toribio",fullName:"Jaime Toribio",slug:"jaime-toribio"}]},{id:"20666",title:"Validation of Protein Biomarkers to Advance the Management of Autoimmune Disorders",slug:"validation-of-protein-biomarkers-to-advance-the-management-of-autoimmune-disorders",signatures:"David S. Gibson, Sorcha Finnegan, Stephen Pennington, Ji Qiu, Joshua LaBaer, Madeleine E. Rooney and Mark W. Duncan",authors:[{id:"40972",title:"Dr.",name:"David",middleName:null,surname:"Gibson",fullName:"David Gibson",slug:"david-gibson"},{id:"40988",title:"Prof.",name:"Mark",middleName:null,surname:"Duncan",fullName:"Mark Duncan",slug:"mark-duncan"},{id:"89331",title:"Dr",name:"Sorcha",middleName:null,surname:"Finnegan",fullName:"Sorcha Finnegan",slug:"sorcha-finnegan"},{id:"89714",title:"Dr.",name:"Madeleine",middleName:null,surname:"Rooney",fullName:"Madeleine Rooney",slug:"madeleine-rooney"},{id:"89766",title:"Prof.",name:"Stephen",middleName:null,surname:"Pennington",fullName:"Stephen Pennington",slug:"stephen-pennington"},{id:"89767",title:"Dr.",name:"Ji",middleName:null,surname:"Qiu",fullName:"Ji Qiu",slug:"ji-qiu"},{id:"90269",title:"Prof.",name:"Joshua",middleName:null,surname:"LaBaer",fullName:"Joshua LaBaer",slug:"joshua-labaer"}]},{id:"20667",title:"Relevance of Autoantibodies for the Classification and Pathogenesis of Neurological Diseases",slug:"relevance-of-autoantibodies-for-the-classification-and-pathogenesis-of-neurological-diseases",signatures:"Simone Mader, Benjamin Obholzer and Markus Reindl",authors:[{id:"39318",title:"Prof.",name:"Markus",middleName:null,surname:"Reindl",fullName:"Markus Reindl",slug:"markus-reindl"},{id:"39330",title:"Dr.",name:"Simone",middleName:null,surname:"Mader",fullName:"Simone Mader",slug:"simone-mader"},{id:"93770",title:"MSc.",name:"Benjamin",middleName:null,surname:"Obholzer",fullName:"Benjamin Obholzer",slug:"benjamin-obholzer"}]},{id:"20668",title:"Preclinical and Predictive Algorithms in Monitoring Patients with Autoimmune Diseases and Their Relatives-at-Risks",slug:"preclinical-and-predictive-algorithms-in-monitoring-patients-with-autoimmune-diseases-and-their-rela",signatures:"Sergey Suchkov, Dmitry Kostyushev, Dmitry Gnatenko, Sevindzh Gadzhieva and Mikhail Paltsev",authors:[{id:"40368",title:"Prof.",name:"Sergey",middleName:"Victorovich",surname:"Suchkov",fullName:"Sergey Suchkov",slug:"sergey-suchkov"},{id:"49152",title:"Dr.",name:"Dmitry",middleName:"Sergeevich",surname:"Kostyushev",fullName:"Dmitry Kostyushev",slug:"dmitry-kostyushev"},{id:"49153",title:"Prof.",name:"Dmitrii",middleName:null,surname:"Gnatenko",fullName:"Dmitrii Gnatenko",slug:"dmitrii-gnatenko"},{id:"49154",title:"Dr.",name:"Sevindj",middleName:null,surname:"Gadjieva",fullName:"Sevindj Gadjieva",slug:"sevindj-gadjieva"},{id:"49155",title:"Prof.",name:"Mihail",middleName:null,surname:"Paltsev",fullName:"Mihail Paltsev",slug:"mihail-paltsev"}]},{id:"20669",title:"Application of Novel Quantitative Proteomic Technologies to Identify New Serological Biomarkers in Autoimmune Diseases",slug:"application-of-novel-quantitative-proteomic-technologies-to-identify-new-serological-biomarkers-in-a",signatures:"Soyoung Lee, Satoshi Serada, Minoru Fujimoto and Tetsuji Naka",authors:[{id:"40263",title:"Prof.",name:"Tetsuji",middleName:null,surname:"Naka",fullName:"Tetsuji Naka",slug:"tetsuji-naka"},{id:"54042",title:"Prof.",name:"Satoshi",middleName:null,surname:"Serada",fullName:"Satoshi Serada",slug:"satoshi-serada"},{id:"54043",title:"Prof.",name:"Minoru",middleName:null,surname:"Fujimoto",fullName:"Minoru Fujimoto",slug:"minoru-fujimoto"},{id:"64673",title:"Dr.",name:"Soyoung",middleName:null,surname:"Lee",fullName:"Soyoung Lee",slug:"soyoung-lee"}]},{id:"20670",title:"Application of Monoclonal Antibody Therapies in Autoimmune Diseases",slug:"application-of-monoclonal-antibody-therapies-in-autoimmune-diseases",signatures:"Adrienn Angyal, Jozsef Prechl, Gyorgy Nagy and Gabriella Sarmay",authors:[{id:"54397",title:"Dr",name:"Adrienn",middleName:null,surname:"Angyal",fullName:"Adrienn Angyal",slug:"adrienn-angyal"},{id:"54406",title:"Prof.",name:"Jozsef",middleName:null,surname:"Prechl",fullName:"Jozsef Prechl",slug:"jozsef-prechl"},{id:"54407",title:"Prof.",name:"Gabriella",middleName:null,surname:"Sarmay",fullName:"Gabriella Sarmay",slug:"gabriella-sarmay"},{id:"145362",title:"Prof.",name:"György M.",middleName:null,surname:"Nagy",fullName:"György M. Nagy",slug:"gyorgy-m.-nagy"}]},{id:"20671",title:"The Emerging Role of Monoclonal Antibodies in the Treatmentof Systemic Lupus Erythematosus",slug:"the-emerging-role-of-monoclonal-antibodies-in-the-treatmentof-systemic-lupus-erythematosus",signatures:"Ewa Robak and Tadeusz Robak",authors:[{id:"34135",title:"Prof.",name:"Tadeusz",middleName:null,surname:"Robak",fullName:"Tadeusz Robak",slug:"tadeusz-robak"},{id:"34143",title:"Prof.",name:"Ewa",middleName:null,surname:"Robak",fullName:"Ewa Robak",slug:"ewa-robak"}]},{id:"20672",title:"Treatment of Pediatric-Onset Lupus Nephritis: A New Option of Less Cytotoxic Immunosuppressive Therapy",slug:"treatment-of-pediatric-onset-lupus-nephritis-a-new-option-of-less-cytotoxic-immunosuppressive-therap",signatures:"Hiroshi Tanaka and Tadaatsu Imaizumi",authors:[{id:"37530",title:"Dr.",name:"Hiroshi",middleName:null,surname:"Tanaka",fullName:"Hiroshi Tanaka",slug:"hiroshi-tanaka"},{id:"52589",title:"Dr.",name:"Tadaatsu",middleName:null,surname:"Imaizumi",fullName:"Tadaatsu Imaizumi",slug:"tadaatsu-imaizumi"}]},{id:"20673",title:"Recent Advances in the Treatment of Neurological Autoimmune Disorders",slug:"recent-advances-in-the-treatment-of-neurological-autoimmune-disorders",signatures:"Jagat R. Kanwar, Bhasker Sriramoju and Rupinder K. Kanwar",authors:[{id:"40068",title:"Prof.",name:"Jagat",middleName:"Rakesh",surname:"Kanwar",fullName:"Jagat Kanwar",slug:"jagat-kanwar"},{id:"53589",title:"Dr.",name:"Rupinder",middleName:null,surname:"Kanwar",fullName:"Rupinder Kanwar",slug:"rupinder-kanwar"}]},{id:"20674",title:"Synthetic Glucocorticoids Modulate Function of Neural Cells: Implications in Autoimmune Neurological Disorders",slug:"synthetic-glucocorticoids-modulate-function-of-neural-cells-implications-in-autoimmune-neurological-",signatures:"Oscar Gonzalez-Perez, Norma A. Moy-Lopez and Jorge Guzman-Muniz",authors:[{id:"35161",title:"Prof.",name:"Oscar",middleName:null,surname:"Gonzalez-Perez",fullName:"Oscar Gonzalez-Perez",slug:"oscar-gonzalez-perez"},{id:"94114",title:"Dr.",name:"Norma",middleName:null,surname:"Moy-Lopez",fullName:"Norma Moy-Lopez",slug:"norma-moy-lopez"},{id:"94115",title:"MSc.",name:"Jorge",middleName:null,surname:"Guzman-Muniz",fullName:"Jorge Guzman-Muniz",slug:"jorge-guzman-muniz"}]},{id:"20675",title:"Intravenous Immunoglobulins in Neurological Diseases: Established and Novel Clinical Applications",slug:"intravenous-immunoglobulins-in-neurological-diseases-established-and-novel-clinical-applications",signatures:"Konstantina G. Yiannopoulou",authors:[{id:"52626",title:"Dr.",name:"Konstantina",middleName:null,surname:"Yiannopoulou",fullName:"Konstantina Yiannopoulou",slug:"konstantina-yiannopoulou"}]},{id:"20676",title:"Cellular Based Therapies for the Treatment of Multiple Sclerosis",slug:"cellular-based-therapies-for-the-treatment-of-multiple-sclerosis",signatures:"James Crooks, Guang-Xian Zhang and Bruno Gran",authors:[{id:"38513",title:"Prof.",name:"Guang-Xian",middleName:null,surname:"Zhang",fullName:"Guang-Xian Zhang",slug:"guang-xian-zhang"},{id:"38803",title:"Dr.",name:"Bruno",middleName:null,surname:"Gran",fullName:"Bruno Gran",slug:"bruno-gran"},{id:"38804",title:"Mr.",name:"James",middleName:null,surname:"Crooks",fullName:"James Crooks",slug:"james-crooks"}]},{id:"20677",title:"Haematopoietic Cell Transplantation and Immunotherapy for Autoimmune Diseases in Children and Adults",slug:"haematopoietic-cell-transplantation-and-immunotherapy-for-autoimmune-diseases-in-children-and-adults",signatures:"Menachem Bitan",authors:[{id:"39092",title:"Dr.",name:"Menachem",middleName:null,surname:"Bitan",fullName:"Menachem Bitan",slug:"menachem-bitan"}]},{id:"20678",title:"Thionamides-Related Vasculitis in Autoimmune Thyroid Disorders: Review of Current Literature and Case Reports",slug:"thionamides-related-vasculitis-in-autoimmune-thyroid-disorders-review-of-current-literature-and-case",signatures:"Elisabetta L. Romeo, Giuseppina T. Russo, Annalisa Giandalia, Provvidenza Villari, Angela A. Mirto, Mariapaola Cucinotta, Giuseppa Perdichizzi and Domenico Cucinotta",authors:[{id:"53938",title:"Dr.",name:"Giuseppina T.",middleName:null,surname:"Russo",fullName:"Giuseppina T. Russo",slug:"giuseppina-t.-russo"},{id:"53940",title:"Dr.",name:"Elisabetta L.",middleName:null,surname:"Romeo",fullName:"Elisabetta L. Romeo",slug:"elisabetta-l.-romeo"},{id:"53941",title:"Dr.",name:"Annalisa",middleName:null,surname:"Giandalia",fullName:"Annalisa Giandalia",slug:"annalisa-giandalia"},{id:"95745",title:"Dr.",name:"Mariapaola",middleName:null,surname:"Cucinotta",fullName:"Mariapaola Cucinotta",slug:"mariapaola-cucinotta"},{id:"95746",title:"Prof.",name:"Giuseppa",middleName:null,surname:"Perdichizzi",fullName:"Giuseppa Perdichizzi",slug:"giuseppa-perdichizzi"},{id:"95749",title:"Prof.",name:"Domenico",middleName:null,surname:"Cucinotta",fullName:"Domenico Cucinotta",slug:"domenico-cucinotta"},{id:"115595",title:"Dr.",name:"Provvidenza",middleName:null,surname:"Villari",fullName:"Provvidenza Villari",slug:"provvidenza-villari"},{id:"115964",title:"Dr.",name:"Angela A.",middleName:null,surname:"Mirto",fullName:"Angela A. Mirto",slug:"angela-a.-mirto"}]},{id:"22843",title:"The Ectopic Germinal Centre Response in Autoimmune Disease and Cancer",slug:"the-ectopic-germinal-centre-response-in-autoimmune-disease-and-cancer",signatures:"David I. Stott and Donna McIntyre",authors:[{id:"110862",title:"Prof.",name:"David",middleName:"Ian",surname:"Stott",fullName:"David Stott",slug:"david-stott"},{id:"136021",title:"Dr.",name:"Donna",middleName:null,surname:"McIntyre",fullName:"Donna McIntyre",slug:"donna-mcintyre"}]},{id:"20680",title:"Myasthenia Gravis: New Insights into the Effect of MuSK Antibodies and Acetylcholinesterase Inhibitors",slug:"myasthenia-gravis-new-insights-into-the-effect-of-musk-antibodies-and-acetylcholinesterase-inhibitor",signatures:"Anna Rostedt Punga",authors:[{id:"38872",title:"Dr.",name:"Anna",middleName:"Rostedt",surname:"Punga",fullName:"Anna Punga",slug:"anna-punga"}]},{id:"20681",title:"Vasoactive Neuropeptides in Autoimmune Diseases",slug:"vasoactive-neuropeptides-in-autoimmune-diseases",signatures:"Ekua W. Brenu, Lotti Tajouri, Donald R. Staines and Sonya M. Marshall-Gradisnik",authors:[{id:"41142",title:"Ms",name:"Ekua",middleName:"Weba",surname:"Brenu",fullName:"Ekua Brenu",slug:"ekua-brenu"},{id:"53185",title:"Prof.",name:"Lotti",middleName:null,surname:"Tajouri",fullName:"Lotti Tajouri",slug:"lotti-tajouri"},{id:"53186",title:"Prof.",name:"Sonya",middleName:null,surname:"Marshall-Gradisnik",fullName:"Sonya Marshall-Gradisnik",slug:"sonya-marshall-gradisnik"},{id:"53187",title:"Prof.",name:"Don",middleName:null,surname:"Staines",fullName:"Don Staines",slug:"don-staines"}]},{id:"20682",title:"Antibody-Proteases in the Pathogenesis of Autoimmune Demyelination and Monitoring Patients with Multiple Sclerosis",slug:"antibody-proteases-in-the-pathogenesis-of-autoimmune-demyelination-and-monitoring-patients-with-mult",signatures:"Dmitry Kostyushev, Dmitry Gnatenko, Mikhail Paltsev, Aleksandr Gabibov and Sergey Suchkov",authors:[{id:"40368",title:"Prof.",name:"Sergey",middleName:"Victorovich",surname:"Suchkov",fullName:"Sergey Suchkov",slug:"sergey-suchkov"},{id:"49152",title:"Dr.",name:"Dmitry",middleName:"Sergeevich",surname:"Kostyushev",fullName:"Dmitry Kostyushev",slug:"dmitry-kostyushev"},{id:"49166",title:"Prof.",name:"Gabibov",middleName:null,surname:"Aleksandr",fullName:"Gabibov Aleksandr",slug:"gabibov-aleksandr"},{id:"107360",title:"Prof.",name:"Dmitrii",middleName:null,surname:"Gnatenko",fullName:"Dmitrii Gnatenko",slug:"dmitrii-gnatenko"},{id:"107467",title:"Prof.",name:"Mikhail",middleName:null,surname:"Paltsev",fullName:"Mikhail Paltsev",slug:"mikhail-paltsev"}]},{id:"20683",title:"Role of Fatty Acids in the Resolution of Autoimmune and Inflammatory Diseases",slug:"role-of-fatty-acids-in-the-resolution-of-autoimmune-and-inflammatory-diseases",signatures:"Elena Puertollano, María A. Puertollano, Gerardo Álvarez de Cienfuegos and Manuel A. de Pablo",authors:[{id:"35125",title:"Dr.",name:"Manuel Antonio",middleName:null,surname:"de Pablo",fullName:"Manuel Antonio de Pablo",slug:"manuel-antonio-de-pablo"},{id:"45341",title:"Dr.",name:"M. Angeles",middleName:null,surname:"Puertollano",fullName:"M. Angeles Puertollano",slug:"m.-angeles-puertollano"},{id:"45342",title:"Dr",name:"Elena",middleName:null,surname:"Puertollano",fullName:"Elena Puertollano",slug:"elena-puertollano"},{id:"45343",title:"Dr.",name:"Gerardo",middleName:null,surname:"Alvarez de Cienfuegos",fullName:"Gerardo Alvarez de Cienfuegos",slug:"gerardo-alvarez-de-cienfuegos"}]},{id:"20684",title:"Autoimmune Disorder and Autism",slug:"autoimmune-disorder-and-autism",signatures:"Xiaohong Li and Hua Zou",authors:[{id:"50228",title:"Dr.",name:"Xiaohong",middleName:null,surname:"Li",fullName:"Xiaohong Li",slug:"xiaohong-li"},{id:"50235",title:"Dr.",name:"Hua",middleName:null,surname:"Zou",fullName:"Hua Zou",slug:"hua-zou"}]},{id:"20685",title:"Chronobiology of and Chronotherapy for Rheumatoid Arthritis",slug:"chronobiology-of-and-chronotherapy-for-rheumatoid-arthritis",signatures:"Hideto To",authors:[{id:"45740",title:"Prof.",name:"Hideto",middleName:null,surname:"To",fullName:"Hideto To",slug:"hideto-to"}]},{id:"20686",title:"Four Aspects of Autoimmunity and How to Regain Tolerance to Self From an Autoimmune Disease Utilizing the Modified Vaccination Technique",slug:"four-aspects-of-autoimmunity-and-how-to-regain-tolerance-to-self-from-an-autoimmune-disease-utilizin",signatures:"Arpad Z. Barabas, Chad D. Cole, Arpad D. Barabas, Rene Lafreniere and Donald M. Weir",authors:[{id:"40002",title:"Dr.",name:"Arpad Z.",middleName:null,surname:"Barabas",fullName:"Arpad Z. Barabas",slug:"arpad-z.-barabas"},{id:"137145",title:"Dr.",name:"Chad",middleName:null,surname:"Cole",fullName:"Chad Cole",slug:"chad-cole"}]},{id:"20687",title:"Parasitic Helminths as Potential Therapeutic Agents Against Autoimmune Disorders",slug:"parasitic-helminths-as-potential-therapeutic-agents-against-autoimmune-disorders",signatures:"Yoshio Osada",authors:[{id:"44076",title:"Dr.",name:"Yoshio",middleName:null,surname:"Osada",fullName:"Yoshio Osada",slug:"yoshio-osada"}]}]}]},onlineFirst:{chapter:{type:"chapter",id:"73188",title:"Probiotics in Allergic Diseases",doi:"10.5772/intechopen.93535",slug:"probiotics-in-allergic-diseases",body:'According to the epidemiological data, half of pediatric population will suffer from allergic diseases until the end of 2020. With that prevalence of more than 30%, they represent the most common disorders of children, adolescents, and adults [1]. A great increase of the prevalence of allergic diseases globally in the last 10 years are best described in a concept of “allergic epidemic” [2]. Germany multi-center allergy study is one of the most important epidemiological studies on allergic diseases, showing age related manifestation of allergic diseases, best described in “allergic march” concept. Allergies start in early infancy as an atopic dermatitis or food allergies, followed with the development of respiratory allergies such as allergic rhinitis and/or asthma [3]. Different from all other chronic diseases such as diabetes mellitus, hypertension, etc., allergic diseases manifest as it has been previously mentioned early in infancy, according to some authors even prenatal. It is well known that allergic diseases are multifactorial, so both environmental and genetic factors may play an important role in their pathogenesis. Identification of prenatal and early postnatal factors is of a great importance for early prevention and intervention [4, 5, 6]. Due to many phenotypes and genotypes as well as different patients’ needs although a great availability of pharmacological options, treating allergies still represents a great challenge. Detection of individual risk factors and identification of predictive markers are of a great importance in primary prevention, early intervention, and immune modulation of a natural course of allergic diseases [7]. It is well know that the development of immune system starts in 11 gestation week with the production of IgE antibodies. Detection of specific IgE antibodies on inhalatory and nutritive allergens is not possible in cord core blood. Except dry skin other clinical manifestation of allergies is not presented in infants. Atopic dermatitis will develop in the first year of life in a case of a great transdermal water loss between 2nd day of life and 2nd month of life. As we have already mentioned, both genetic and “in utero” environmental factors are responsible for allergy development. Uni or bilateral positive family history of allergies, diet habits, obesity, smoking, and drug use during pregnancy, season at time of birth as well as gestational age, the way of delivery are known to be an very important risk factors. Primary prevention and early intervention can prevent the development of atopic march. It includes treating skin with emollient creams, breast feeding in the first year of life, probiotics, and vitamin D during pregnancy and during the first year of life, early introduction of solid food as well as allergens [8]. Many hypotheses on causes of the increase in allergic diseases have been suggested. One of the most investigated hypotheses is “hygiene hypothesis”, helping us to understand early-life events. It is well known that early exposure to common bacterial triggers such as endotoxins, LPS, or hemlines might have an allergy preventive effect.
The second worldwide accepted concept of reduced exposure (exposure to small amounts of foreign proteins) in exclusively breastfeeding children may rather lead to tolerance than to clinical allergic disease. Other routes of exposure via inhalation or via the skin cannot be totally avoided; interventional studies on avoidance/reduction of indoor allergen exposure (house dust mite and cat) have not shown convincing results. EAACI evidence-based recommendation for prevention of food and respiratory allergy prevention includes: no special diet during pregnancy or for the lactating mother, exclusively breastfeeding for 4–6 months, if needed hypoallergenic formula is recommended, avoids exposure to tobacco smoke, and avoids pets at home [9, 10].
All plants, animals, and humans live in close association with microbial organisms. The Human Microbiome Project has showed that the human body contains trillions of microorganisms which outnumber human cells by 10 to 1. Their genes encoded proteins essential for human survival. The role of microbes is of particular importance in gastrointestinal tract where they are involved in break down proteins, lipides, and carbohydrates in monomers suitable for absorption [11]. They are also involved in vitamin synthesis as well as in immuno modulation. Mice raised under germ free conditions have suffered from deficit in innate and adaptive immunity suggesting that the microbiome may play a crucial role in maturation of child immune system. Furthermore, experimental studies in germ free mice showed that those mice developed easily allergic diseases. Reconstruction of neonate mice with a conventional microbic protected the animals from allergic diseases.
The protective role of exposure to a wide diversity of microbial is best described in children raised on traditional farms [12]. Those children have a much lower prevalence of asthma, have fever, and allergic sensitization in comparison to children grown up in urban areas expect those who are exposed to environmental microbes (those who keep dogs indoors) [13].
Gut microbiota is one of the most investigated topics in the last couple of years. Human microbiota represent a community of commensal, symbiotic, and pathogenic bacteria that live in and on human body with the widest and probably most important community in human gut.
Several thousand years ago, ancient Roman scientist Gaius Plinius Secundus Maior recommended fermented milk to treat gastrointestinal problems. Benefits of probiotics contained in sour milk cream or yogurt are mentioned even in Holy Bible. In 1900, Moro isolated the first bacteria that produced lactic acid Bacillus acidophilus later called Lactobacillus acidophilus. Ilja Iljic Mecnikov was the first scientist who proved benefits of so-called good lactic acid produced bacteria particularly on gastrointestinal tract. In his hypothesis on autointoxication, he claimed that human body is intoxicated with toxins and pathogenic bacteria from food and he proposed consumption of lactic acid bacteria contained in Bulgarian yogurt in treating this disorder. The bacteria isolated from Bulgarian yogurt later became famous under name Lactobacillus delbrueckii strain, substring bulgaricus.
Henri Tiser from Pasteur Institute isolated Bifidobacterium bifidum from the feces of health breastfeeding infants and advised that bacteria for treating infants with diarrhea. Anri Boulardii French microbiologist discovered and isolated Saccharomyces boulardii that was used in South-eastern Asia for thousands of years for treating cholera [14]. Lactobacillus rhamnosus GG strain is one of the most investigated bacteria strain. IT was discovered by two scientists Sherwood Gorbach and Bari Goldin in 1983 [15]. Word probiotic comes from a Greek word pro+bios that means “for life” and it is used for the first time in 1953 when Kollath described organic and nonorganic food additives that are necessary for treating malnutrition. In 1965, Lilly and Still well described probiotics as substances that are produced by one microbe in order to stimulate the growth of another microbe contrary to the term antibiotics.
In 2001, World Health Organization (WAO) defined probiotics as live microbes that can have a positive effects on wellbeing if they use in a proper way and quantities.
In 2002, Food and Agriculture Organization and WHO published recommendation for probiotics in food [16]. In 2014, WHO reviewed probiotic definition in terms of needs for evidence base clinical efficacy of certain probiotics strains. Nowadays, worldwide accepted definition of probiotics is: probiotics are live microbes which benefits and positive effects on human health if they use in adequate quantities are proven in control clinical studies [17, 18]. Old concept of sterile “in utero” development has been abandoned. According to recent studies, colonization of fetal gut started in utero predominantly with maternal oral, vaginal, and gut microbiota. Neither placenta neither amniotic fluid is sterile; fetus received its first dose of probiotics with the ingestion of amniotic fluid [19, 20].
The most relevant prenatal factors for the formation of gut microbiota are maternal hygiene, particularly dental, diet, infectious, and antibiotics usage. Perinatal factors are also antibiotics during delivery, gestational age, the way of delivery, and medical staff in delivery room [21]. Post natal factors include: skin to skin contact, breast feeding, pets, baby bathing, as well as other environmental factors. To summarize all those maternal as well as placental factors have a key role in the development of a child gut microbiota. Moreover, the presence of pathogenic bacteria in amniotic fluid can induce a cascade of inflammatory response and prostaglandin synthesis that leads to the uterus contraction and preterm delivery. In utero infection particularly chorioamnionitis presents key risk factors for preterm delivery.
There is a substantial body of evidence supporting transplacental immune regulation during pregnancy. Maternal IgGs loaded with, for example, microbial components from the mother cross the fetal-maternal barrier by an active process from 13 weeks gestation [22], conveying temporary passive immunity [23] and influencing fetal innate immune development [24]. In contrast, cellular components are generally separated by the placenta, with some leakage in both directions without preference toward a specific cell type [25]. This cellular leakage is functionally important, as maternal cells residing in fetal lymph nodes induce fetal regulatory T cells that suppress antimaternal immunity [26]. Transplacental immune regulation may be further mediated by cytokines and hormones [27], through bacterial products such as short-chain fatty acids or lipopolysaccharides (LPS) [28, 29].
Santner-Nanan et al. have demonstrated a strong correlation of peripheral blood Treg cells between the mother and the fetus [30]. In contrast, there was no significant Treg cell correlation between the father and the fetus, implicating that the specific context of pregnancy, that is, the placental environment, rather than haploidentical genetic parental similarity to the fetus, is responsible for this correlation. Maternal infant alignment in Treg cells appeared to be mediated by IL-10, a pleiotropic cytokine with potent immunoregulatory properties [31]. Treg cells are characterized by increased expression of the IL-10 receptor-α (IL-10RA), making them more sensitive to the effects of IL-10. The IL-10 regulates Bcl-2 expression in Treg cells, which could contribute to Treg cell survival in both the mother and the infant [32].
In the context of alignment between maternal and infant Treg, the evidence that has been studied suggesting an association between complicated pregnancy with preeclampsia and an increased risk of asthma, as well as allergic offspring sensitization [32]. A potential antecedent common to both mother and child is the mother’s microbiome and its metabolic products, including short-chain fatty acids (SCFA).
Maternal IgG may play a key role in mediating the association between the maternal microbiome and fetal immune development. Of the five immunoglobulin classes, maternal IgG is the only antibody that significantly crosses the human placenta [22]. The active transport of IgG occurs via the neonatal Fc receptor (FcRn) within the syncytiotrophoblast (ST) cells at the surface of the chorionic villi of the placenta. Once bound to the FcRn receptor, IgG is packaged in endosomes and protected from degradation until it dissociates into the fetal circulation [33, 34].
This materno-fetal IgG transport is an important mechanism that confers passive humoral immunity to the fetus, so that after birth, the infant is protected against infections while its own immune system develops [22, 28]. Allergen-specific maternal IgG also plays a role in the induction of immune tolerance in infant [35]. Until recently, maternal IgG transfer during gestation had only been linked to fetal humoral immunity, but there is now good evidence that maternal IgG also plays a crucial in fetal innate immune development [24]. 61.1% of bacteria isolated in meconium of preterm infants (younger than 33 gestational weeks) are those that are also isolated from amniotic fluid, the majority of them belong to the three strains: Enterobacteria, Enterococcus, Lactobacillus, Photorhabdus, and Tanarella. Those bacteria are found to have a negative correlation with gestational age which suggests their important role in initiation of preterm delivery [36, 37].
Studies have been already proven that certain bacteria in amniotic fluid can provoke preterm labor. Preterm babies in comparison to term babies have more anaerobe bacteria. This fact can be described with several facts: preterm babies are at high risk of postnatal complications such as asphyxia, acute respiratory distress development, neonatal sepsis, necrotic enterocolitis, etc. In terms of that they are prescribed more often both oxygen and antibiotics treatment that are together increase hospitalization days particularly in NICU – Neonatal Intensive Care Unit. Only three bacteria strains are found in preterm babies at 10 days of life: Enterobacteria (E. coli and Klebsiella), Enterococcus faecalis and Staphylococcus aureus, and haemolyticus. On the other side, colonization with bifidobacteria in preterm infants is postponed [38]. The way of delivery is the third factor for gut microbiota development. A great number of data suggested that cesarean section alongside with the intrapartal antibiotics usage is independent risk factors for gut disbiosis. During vaginal delivery, an infant become colonize with maternal vaginial bacteria. Grounlad and authors showed that even 6 months after delivery gut of infants born on caesarian section contain less bacteria of Bacteroides fragilis strains. Finland study has proven more bacteria of Clostridium strain in children born on vaginal way in comparison to those born via cesarean section. Lactobacillus, Prevotella, and Sneathia strains are predominant in gut microbiota of children born vaginal way, while on the other side, Staphylococcus, Corynebacterium and Propioni bacterium strains are dominant in another group of children born on caesarian session [39]. Postnatal prevention includes at the first place breast feeding followed with the onetime introduction of solid food and allergens. Breastfed children are proved to have predominantly bifidobacteria strains in their gut microbiota while infants fed with formulas had more bacterioides strains. It is well know that mothers milk contain special ingredients that can have immuno modulation effects on infants immune system. Rutava and authors showed that there is a special interaction between gut microbiota and transforming growth factor beta from human milk that are most potent antiinflammatory factor of a great importance also for maturation of intestinal tract as well as the production of IgA antibodies. According to this hypothesis bacteria from uterus have been actively transported in breast gland and secrete in human milk and in that way transfer immune tolerance to the infants. Moreover, it is proven that if mother use probiotics particularly Lactobacillus strain during breast feeding increase the number of bifidobacteria in gut of breast-fed infants [40].
Intestinal microbiology of early life has been best described in the first thousand days concept (PAI 2014). According to that hypothesis, the first thousand days of early life (230 days prenatal and 2 years postnatal) are crucial for establishing of symbiosis for the whole life. This is one of the most important mechanisms of evolution f as intestinal microbiota is in close relation with etiopathogenesis of allergic, autoimmune disease, and tumors [41].
The development of allergic diseases is best described in a concept of atopic march. Allergies start in early infancy with atopic dermatitis, followed by IgE mediated food allergies and asthma development ended up with allergic rhinitis. As we have already mentioned early, intervention is crucial for interrupt atopic march and preventing allergies.
It is very well known for almost 20 years that Lactobacillus rhamnosus GG strain 1 × 106 cfu/g given to atopic pregnant women followed with 6 months of postnatal administration to infants can significantly prevent the development of atopic dermatitis at the age of 2 years. Furthermore, protective effects were long lasting for two more years. On the other side, significant increase of atopic dermatitis prevalence has been recorded in the control group in the follow up period [42]. Double blind, randomized, placebo control PandA study investigated the preventive effects of three strains combination Bifidobacterium bifidum W23B (1 × 109 cfg/g), Bifidobacterium lactase W52 (1 × 109 cfu/g) and Lactococcus lactic W58 (1 × 109cfu/l). Administration of this combination to atopic mothers in the last 6 weeks of pregnancy and infants in the first year of life showed preventive effects in the first 3 months of life with the significant changes in intestinal microbiota and decrease in the level of IL-5 production [43]. Those results are in accordance with the results of Zhang meta-analysis who showed that prenatal and postnatal administration of probiotics may reduce the risk of atopic disease in families under risk of allergy and hypersensitivity reaction to food. According to those authors, administration of probiotics to infants born via cesarean section can even benefit more from probiotics [44]. Probiotics are also have positive impact on SCORAD reduction in placebo control study on 27 infants with atopic dermatitis who were breast-fed and received Bifidobacterium lactose Bb-12 1 × 109 cfu/g and Lactobacillus GG 3 × 108 cfu/g in comparison to place group [45]. Majamaa and collaborators showed significant improvement of atopic dermatitis and reduction in fetal concentration of antitripsin-1 and TNF as well as up regulation of Il-10 and down regulation of pro inflammatory cytokines and total IgE antibodies level in infants on hypoallergenic milk formulas who concomitantly received Lactobacillus rhamnosus GG 5 × 108 cfu/g in comparison to placebo group [46]. Pessi’s study showed similar Il-10 level improvement in children allergic to cow milk proteins who received Lactobacillus rhamnosus GG 2 × 1010 cfu/g pro doses [47]. Those results are controversial in terms of asthma and wheezing prevention. Two meta-analysis of Elazab and coauthors and Azad and coauthors have failed to prove positive effects of probiotics administration in pregnancy and postnatal on the asthma and wheezing development. Recent meta-analysis of randomized control study of Wei and coauthors did not find enough results to support recommendation of probiotics for asthma prevention in infants [48]. In Filipovic and coauthors study, it is found that Lactobacillus rhamnosus GG (LGG) formulation with Zn and vitamin D3 supplementation during the postnatal period (in infancy and early childhood) reduce the severity of atopic dermatitis. Type of delivery, type of feeding breast-feeding versus adapted milk formulas were not found to be statistically associated with risk of atopic dermatitis [49]. According to European Academy for Allergy and Clinical Immunology, there is no official recommendation for probiotic treatment in patients with food allergy [50]. Overall probiotics are proven to have positive effects in primary prevention of allergies even prenatal. According to the results from several studies probiotics have both local and systemic effects. They act locally on the intestinal tract via promoting immune tolerance. Systemically, they act antiinflammatory reducing Th17 response and stimulating TLR and Th1 immune response [51, 52].
According to the epidemiological data, allergic diseases have been increasing in the last decades, despite a great variety of effective treatment available. Standard pharmacological treatment of allergies is only symptomatic without the capability to change the natural course of allergic disease. Immunotherapy is the only treatment with the immunomodulatory effects. The second option is probiotics that are not only capable to prevent atopic march but also to prevent the development of allergic disease prenatal. Despite a great number of placebo control randomized studies and meta-analysis, we are still looking for the best probiotic and adequate dose for each level of intervention: prenatal, early postnatal as well as for different manifestation of allergic diseases (atopic dermatitis, food allergies, asthma, and allergic rhinitis).
If your research is financed through any of the below-mentioned funders, please consult their Open Access policies or grant ‘terms and conditions’ to explore ways to cover your publication costs (also accessible by clicking on the link in their title).
\n\nIMPORTANT: You must be a member or grantee of the listed funders in order to apply for their Open Access publication funds. Do not attempt to contact the funders if this is not the case.
",metaTitle:"List of Funders by Country",metaDescription:"If your research is financed through any of the below-mentioned funders, please consult their Open Access policies or grant ‘terms and conditions’ to explore ways to cover your publication costs (also accessible by clicking on the link in their title).",metaKeywords:null,canonicalURL:"/page/open-access-funding-funders-list",contentRaw:'[{"type":"htmlEditorComponent","content":"Book Chapters and Monographs
\\n\\nMonographs Only
\\n\\nBook Chapters and Monographs
\\n\\n\\n\\nBook Chapters and Monographs
\\n\\nBook Chapters and Monographs
\\n\\nBook Chapters and Monographs
\\n\\nBook Chapters and Monographs
\\n\\nBook Chapters and Monographs
\\n\\nBook Chapters and Monographs
\\n\\nBook Chapters and Monographs
\\n\\nMonographs Only
\\n\\nLITHUANIA
\\n\\nBook Chapters and Monographs
\\n\\n\\n\\nBook Chapters and Monographs
\\n\\n\\n\\nBook Chapters and Monographs
\\n\\n\\n\\nSWITZERLAND
\\n\\nBook Chapters and Monographs
\\n\\nBook Chapters and Monographs
\\n\\n\\n\\nBook Chapters and Monographs
\\n\\nBook Chapters and Monographs
\n\nMonographs Only
\n\nBook Chapters and Monographs
\n\n\n\nBook Chapters and Monographs
\n\n\n\nBook Chapters and Monographs
\n\nBook Chapters and Monographs
\n\nBook Chapters and Monographs
\n\nBook Chapters and Monographs
\n\n\n\nBook Chapters and Monographs
\n\nBook Chapters and Monographs
\n\n\n\nMonographs Only
\n\n\n\nLITHUANIA
\n\nBook Chapters and Monographs
\n\n\n\nBook Chapters and Monographs
\n\n\n\nBook Chapters and Monographs
\n\n\n\nSWITZERLAND
\n\nBook Chapters and Monographs
\n\n\n\nBook Chapters and Monographs
\n\n\n\nBook Chapters and Monographs
\n\n